Health
COVID-19 Testing Stocks Move Lower After Abbott Receives EUA For 15-Minute Test – Benzinga
Abbott Laboratories (NYSE: ABT) announced late Wednesday the receipt of emergency use authorization from the FDA for its $5, 15-minute COVID-19 antigen …
Abbott Laboratories (NYSE: ABT) announced late Wednesday the receipt of emergency use authorization from the FDA for its $5, 15-minute COVID-19 antigen test.
Abbott’s BinaxNOW could be transformative, Morgan Stanley analyst David Lewis said in a note.
The test is bigger and better than expected, given the $5 price point; the fact that it’s a nasal swab; its better-than-expected performance; and a higher shipment volume, the analyst said.
The Sympathy Move: The announcement, though catalyzing…
-
Business14 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General12 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
General23 hours agoWestern Bulldogs extend Essendon’s losing streak with 57 point thrashing
-
General21 hours agoAustralia solved civilisation’s problems